drugset / Trial / NCT02152579

Efficacy and Safety of Monocordil Manufactured by Laboratórios Baldacci

NCT02152579

Phase 3 Unknown 86 enrolled Laboratórios Baldacci S.A
NaSingle-groupOpen-labelTreatment

Summary

Phase III clinical study for the evaluation of clinic and cardiologic effects of isosorbide mononitrate from the incidence of events (angina episodes). This is an open, comparative, monocentric trial. The hypothesis, regarding the number of angina episodes, to be tested are: * H0: μD = 0 ot H0: μAfter = μBefore * HA: μD ≠ 0 ot HA: μBefore ≠ μAfter

Timeline

Start
2014-07
Primary completion
2014-09
Completion
2014-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Isosorbide Mononitrate Other / unclassified 20 mg

Indications

No indication recorded.